Recurrence-free survival | |||
---|---|---|---|
Variable | HR | 95% CI | Pvalue |
Age at diagnosis | 1.00 | 0.97-1.03 | 0.951 |
Nodal status | Â | Â | Â |
   Negative | 1 |  |  |
   Positive | 3.08 | 1.66-5.73 | <0.001 |
T stage | Â | Â | Â |
   T1 | 1 |  |  |
   T2-4 | 1.31 | 0.66-2.58 | 0.439 |
p4E-BP1 S65 | 1.62 | 1.13-2.31 | 0.008 |
Overall survival | |||
Variable | HR | 95% CI | P value |
Age at diagnosis | 1.04 | 1.01-1.07 | 0.003 |
Nodal status | Â | Â | Â |
   Negative |  |  |  |
   Positive | 1.29 | 0.75-2.23 | 0.355 |
T stage | Â | Â | Â |
   T1 |  |  |  |
   T2-4 | 1.02 | 0.58-1.81 | 0.945 |
pS6 S235/236 | 1.73 | 1.03-2.90 | 0.039 |
eEF2K | 2.19 | 1.35-3.56 | 0.002 |
Pdcd4 | 0.42 | 0.25-0.70 | 0.001 |